Patent · US Active

Antibody induced cell membrane wounding

US8377435B2 · kind B2 · utility

18Cited by
2References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 4, 2005
Grant dateFeb 19, 2013
Priority date
Expiry dateNov 30, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/21
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for inducing cell membrane wounding, cell permeabilization and cell killing are provided. The composition comprises a polyvalent agent that binds to a highly expressed cell surface antigen present on the surface of a cell. Preferably, the cell surface antigen is associated with the cytoskeleton of the cell. A preferred polyvalent agent is an IgM, and enhanced cell wounding and killing can be provided by the addition of a crosslinking agent. At sublethal concentrations in vivo, the cell wounding antibodies permeabilize cells and dramatically enhance response to chemotherapeutic agents, even in patients refractory to the chemotherapeutic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.